Categories
Cosmetics

PCPC Applauds Cosmetics Regulatory Reform in Consolidated Appropriations Act of 2023

… federal regulatory oversight of cosmetics and personal care products … uniform national framework for cosmetics regulation. The long- … for the science-driven beauty and personal care industry … a contemporary approach to cosmetics oversight and further strengthen …

Sponsored by:

Melissa Juried Kriebel

IceCream Sunscreen

IceCreamSunscreen

image

Congress included legislation that modernizes federal regulatory oversight of cosmetics and personal care products. The legislation is in the Consolidated Appropriations Act of 2023. The Personal Care Products Council (PCPC) and its member companies applauded the move. According to PCPC, it creates a comprehensive and uniform national framework for cosmetics regulation. The long-awaited legislation advances product safety and innovation for the science-driven beauty and personal care industry and reinforces consumer confidence, said PCPC executives.

“We greatly appreciate Chairwoman Patty Murray, Ranking Member Richard Burr, Chairman Frank Pallone, Jr. and Ranking Member Cathy McMorris Rodgers for their leadership. This truly historic moment took over a decade, bringing together a diverse group of stakeholders to support a contemporary approach to cosmetics oversight and further strengthen consumer trust in the products they use every day,” said PCPC President and CEO Lezlee Westine. “This landmark legislation would not have been possible without their leadership and commitment.”

PCPC Executive Vice President of Government Affairs Karin Ross added: “We entered this process advocating for well-crafted, science-based federal reforms to enhance our industry’s ability to innovate and to modernize regulation that has largely been unchanged for 80 years. These members of Congress guided that process. Thanks to their leadership, the Food and Drug Administration will have the necessary tools to ensure consistent regulation of cosmetics and personal care products.”

PCPC said it looks forward to working with the US Food and Drug Administration and key stakeholders to implement this legislation.

Leave a Reply

Your email address will not be published. Required fields are marked *